Assessing the microlesion effect of subthalamic deep brain stimulation surgery with FDG PET.

OBJECT The authors investigated whether the insertion of deep brain stimulation electrodes into the subthalamic nucleus can alter regional brain metabolism in the absence of stimulation. METHODS Six patients with Parkinson disease (PD) underwent preoperative FDG PET scanning, and again after STN electrode implantation with stimulation turned off. RESULTS Compared with baseline values, glucose utilization was reduced in the postoperative off-stimulation scans in the putamen/globus pallidus and in the ventral thalamus (p < 0.01), and there was increased metabolism in the sensorimotor cortex and cerebellum (p < 0.005). The expression of a specific PD-related spatial covariance pattern measured in the FDG PET data did not change after electrode implantation (p = 0.36), nor was there a significant change in clinical motor ratings (p = 0.44). Differences in PD-related spatial covariance pattern expression among the patients after electrode implantation did, however, correlate with the number of microelectrode recording trajectories placed during surgery (r = -0.82, p < 0.05). CONCLUSIONS These findings suggest that electrode implantation can impart a microlesion effect on regional brain function. Nonetheless, these local changes did not cross the threshold of network modulation needed to achieve clinical benefit.

[1]  Ali R. Rezai,et al.  Neurophysiological Refinement of Subthalamic Nucleus Targeting , 2002, Neurosurgery.

[2]  Alberto Pupi,et al.  Changes in regional cerebral blood flow caused by deep-brain stimulation of the subthalamic nucleus in Parkinson's disease. , 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[3]  V. Dhawan,et al.  Abnormal Metabolic Network Activity in Parkinson'S Disease: Test—Retest Reproducibility , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[4]  Didier Hannequin,et al.  Microsubthalamotomy: An immediate predictor of long‐term subthalamic stimulation efficacy in Parkinson disease , 2008, Movement disorders : official journal of the Movement Disorder Society.

[5]  Alain Dagher,et al.  Subthalamic deep brain stimulation does not induce striatal dopamine release in Parkinson's disease , 2003, Neuroreport.

[6]  V. Sturm,et al.  Subthalamic Nucleus Stimulation Restores Glucose Metabolism in Associative and Limbic Cortices and in Cerebellum: Evidence from a FDG-PET Study in Advanced Parkinson's Disease , 2004, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[7]  Anna Barnes,et al.  Evolving metabolic changes during the first postoperative year after subthalamotomy. , 2003, Journal of neurosurgery.

[8]  V. Dhawan,et al.  Modulation of metabolic brain networks after subthalamic gene therapy for Parkinson's disease , 2007, Proceedings of the National Academy of Sciences.

[9]  David Eidelberg,et al.  Metabolic correlates of subthalamic nucleus activity in Parkinson's disease. , 2008, Brain : a journal of neurology.

[10]  C. Mariani,et al.  Brain flow changes before and after deep brain stimulation of the subthalamic nucleus in Parkinson’s disease , 2003, Neurological Sciences.

[11]  V. Dhawan,et al.  Network modulation in the treatment of Parkinson's disease. , 2006, Brain : a journal of neurology.

[12]  Anna Barnes,et al.  Network modulation by the subthalamic nucleus in the treatment of Parkinson's disease , 2006, NeuroImage.

[13]  David Eidelberg,et al.  Assessment of the progression of Parkinson's disease: a metabolic network approach , 2007, The Lancet Neurology.

[14]  C. Granziera,et al.  Sub-acute delayed failure of subthalamic DBS in Parkinson's disease: the role of micro-lesion effect. , 2008, Parkinsonism & related disorders.

[15]  E. Montgomery STN-DBS ACTIVATES THE TARGET AREA IN PARKINSON DISEASE , 2009, Neurology.